Copyright Reports & Markets. All rights reserved.

Global Endoscopic Hemostatic Powder Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Endoscopic Hemostatic Powder Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Polysaccharide Type
    • 1.3.3 Cellulose Type
    • 1.3.4 Gelatin Type
    • 1.3.5 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Endoscopic Hemostatic Powder Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital
    • 1.4.3 Clinic
    • 1.4.4 Others
  • 1.5 Global Endoscopic Hemostatic Powder Market Size & Forecast
    • 1.5.1 Global Endoscopic Hemostatic Powder Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Endoscopic Hemostatic Powder Sales Quantity (2021-2032)
    • 1.5.3 Global Endoscopic Hemostatic Powder Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 BD
    • 2.1.1 BD Details
    • 2.1.2 BD Major Business
    • 2.1.3 BD Endoscopic Hemostatic Powder Product and Services
    • 2.1.4 BD Endoscopic Hemostatic Powder Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 BD Recent Developments/Updates
  • 2.2 Johnson & Johnson
    • 2.2.1 Johnson & Johnson Details
    • 2.2.2 Johnson & Johnson Major Business
    • 2.2.3 Johnson & Johnson Endoscopic Hemostatic Powder Product and Services
    • 2.2.4 Johnson & Johnson Endoscopic Hemostatic Powder Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Johnson & Johnson Recent Developments/Updates
  • 2.3 Qingdao Zhonghui Health Industrial Group
    • 2.3.1 Qingdao Zhonghui Health Industrial Group Details
    • 2.3.2 Qingdao Zhonghui Health Industrial Group Major Business
    • 2.3.3 Qingdao Zhonghui Health Industrial Group Endoscopic Hemostatic Powder Product and Services
    • 2.3.4 Qingdao Zhonghui Health Industrial Group Endoscopic Hemostatic Powder Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Qingdao Zhonghui Health Industrial Group Recent Developments/Updates
  • 2.4 Pfizer
    • 2.4.1 Pfizer Details
    • 2.4.2 Pfizer Major Business
    • 2.4.3 Pfizer Endoscopic Hemostatic Powder Product and Services
    • 2.4.4 Pfizer Endoscopic Hemostatic Powder Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Pfizer Recent Developments/Updates
  • 2.5 Success Bio-Tech
    • 2.5.1 Success Bio-Tech Details
    • 2.5.2 Success Bio-Tech Major Business
    • 2.5.3 Success Bio-Tech Endoscopic Hemostatic Powder Product and Services
    • 2.5.4 Success Bio-Tech Endoscopic Hemostatic Powder Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Success Bio-Tech Recent Developments/Updates
  • 2.6 Hangzhou Singclean Medical Products
    • 2.6.1 Hangzhou Singclean Medical Products Details
    • 2.6.2 Hangzhou Singclean Medical Products Major Business
    • 2.6.3 Hangzhou Singclean Medical Products Endoscopic Hemostatic Powder Product and Services
    • 2.6.4 Hangzhou Singclean Medical Products Endoscopic Hemostatic Powder Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Hangzhou Singclean Medical Products Recent Developments/Updates
  • 2.7 Medtrade Products
    • 2.7.1 Medtrade Products Details
    • 2.7.2 Medtrade Products Major Business
    • 2.7.3 Medtrade Products Endoscopic Hemostatic Powder Product and Services
    • 2.7.4 Medtrade Products Endoscopic Hemostatic Powder Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Medtrade Products Recent Developments/Updates
  • 2.8 Beijing Tech-Bio-Med Medical Equipment
    • 2.8.1 Beijing Tech-Bio-Med Medical Equipment Details
    • 2.8.2 Beijing Tech-Bio-Med Medical Equipment Major Business
    • 2.8.3 Beijing Tech-Bio-Med Medical Equipment Endoscopic Hemostatic Powder Product and Services
    • 2.8.4 Beijing Tech-Bio-Med Medical Equipment Endoscopic Hemostatic Powder Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Beijing Tech-Bio-Med Medical Equipment Recent Developments/Updates
  • 2.9 Baxter (PerClot)
    • 2.9.1 Baxter (PerClot) Details
    • 2.9.2 Baxter (PerClot) Major Business
    • 2.9.3 Baxter (PerClot) Endoscopic Hemostatic Powder Product and Services
    • 2.9.4 Baxter (PerClot) Endoscopic Hemostatic Powder Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Baxter (PerClot) Recent Developments/Updates
  • 2.10 BioCer Entwicklungs
    • 2.10.1 BioCer Entwicklungs Details
    • 2.10.2 BioCer Entwicklungs Major Business
    • 2.10.3 BioCer Entwicklungs Endoscopic Hemostatic Powder Product and Services
    • 2.10.4 BioCer Entwicklungs Endoscopic Hemostatic Powder Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 BioCer Entwicklungs Recent Developments/Updates
  • 2.11 Hemostasis
    • 2.11.1 Hemostasis Details
    • 2.11.2 Hemostasis Major Business
    • 2.11.3 Hemostasis Endoscopic Hemostatic Powder Product and Services
    • 2.11.4 Hemostasis Endoscopic Hemostatic Powder Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Hemostasis Recent Developments/Updates
  • 2.12 Qingdao Biotemed Biomaterials
    • 2.12.1 Qingdao Biotemed Biomaterials Details
    • 2.12.2 Qingdao Biotemed Biomaterials Major Business
    • 2.12.3 Qingdao Biotemed Biomaterials Endoscopic Hemostatic Powder Product and Services
    • 2.12.4 Qingdao Biotemed Biomaterials Endoscopic Hemostatic Powder Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Qingdao Biotemed Biomaterials Recent Developments/Updates
  • 2.13 Aegis Lifesciences
    • 2.13.1 Aegis Lifesciences Details
    • 2.13.2 Aegis Lifesciences Major Business
    • 2.13.3 Aegis Lifesciences Endoscopic Hemostatic Powder Product and Services
    • 2.13.4 Aegis Lifesciences Endoscopic Hemostatic Powder Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Aegis Lifesciences Recent Developments/Updates

3 Competitive Environment: Endoscopic Hemostatic Powder by Manufacturer

  • 3.1 Global Endoscopic Hemostatic Powder Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Endoscopic Hemostatic Powder Revenue by Manufacturer (2021-2026)
  • 3.3 Global Endoscopic Hemostatic Powder Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Endoscopic Hemostatic Powder by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Endoscopic Hemostatic Powder Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Endoscopic Hemostatic Powder Manufacturer Market Share in 2025
  • 3.5 Endoscopic Hemostatic Powder Market: Overall Company Footprint Analysis
    • 3.5.1 Endoscopic Hemostatic Powder Market: Region Footprint
    • 3.5.2 Endoscopic Hemostatic Powder Market: Company Product Type Footprint
    • 3.5.3 Endoscopic Hemostatic Powder Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Endoscopic Hemostatic Powder Market Size by Region
    • 4.1.1 Global Endoscopic Hemostatic Powder Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Endoscopic Hemostatic Powder Consumption Value by Region (2021-2032)
    • 4.1.3 Global Endoscopic Hemostatic Powder Average Price by Region (2021-2032)
  • 4.2 North America Endoscopic Hemostatic Powder Consumption Value (2021-2032)
  • 4.3 Europe Endoscopic Hemostatic Powder Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Endoscopic Hemostatic Powder Consumption Value (2021-2032)
  • 4.5 South America Endoscopic Hemostatic Powder Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Endoscopic Hemostatic Powder Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Endoscopic Hemostatic Powder Sales Quantity by Type (2021-2032)
  • 5.2 Global Endoscopic Hemostatic Powder Consumption Value by Type (2021-2032)
  • 5.3 Global Endoscopic Hemostatic Powder Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Endoscopic Hemostatic Powder Sales Quantity by Application (2021-2032)
  • 6.2 Global Endoscopic Hemostatic Powder Consumption Value by Application (2021-2032)
  • 6.3 Global Endoscopic Hemostatic Powder Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Endoscopic Hemostatic Powder Sales Quantity by Type (2021-2032)
  • 7.2 North America Endoscopic Hemostatic Powder Sales Quantity by Application (2021-2032)
  • 7.3 North America Endoscopic Hemostatic Powder Market Size by Country
    • 7.3.1 North America Endoscopic Hemostatic Powder Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Endoscopic Hemostatic Powder Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Endoscopic Hemostatic Powder Sales Quantity by Type (2021-2032)
  • 8.2 Europe Endoscopic Hemostatic Powder Sales Quantity by Application (2021-2032)
  • 8.3 Europe Endoscopic Hemostatic Powder Market Size by Country
    • 8.3.1 Europe Endoscopic Hemostatic Powder Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Endoscopic Hemostatic Powder Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Endoscopic Hemostatic Powder Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Endoscopic Hemostatic Powder Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Endoscopic Hemostatic Powder Market Size by Region
    • 9.3.1 Asia-Pacific Endoscopic Hemostatic Powder Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Endoscopic Hemostatic Powder Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Endoscopic Hemostatic Powder Sales Quantity by Type (2021-2032)
  • 10.2 South America Endoscopic Hemostatic Powder Sales Quantity by Application (2021-2032)
  • 10.3 South America Endoscopic Hemostatic Powder Market Size by Country
    • 10.3.1 South America Endoscopic Hemostatic Powder Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Endoscopic Hemostatic Powder Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Endoscopic Hemostatic Powder Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Endoscopic Hemostatic Powder Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Endoscopic Hemostatic Powder Market Size by Country
    • 11.3.1 Middle East & Africa Endoscopic Hemostatic Powder Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Endoscopic Hemostatic Powder Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Endoscopic Hemostatic Powder Market Drivers
  • 12.2 Endoscopic Hemostatic Powder Market Restraints
  • 12.3 Endoscopic Hemostatic Powder Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Endoscopic Hemostatic Powder and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Endoscopic Hemostatic Powder
  • 13.3 Endoscopic Hemostatic Powder Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Endoscopic Hemostatic Powder Typical Distributors
  • 14.3 Endoscopic Hemostatic Powder Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Endoscopic Hemostatic Powder market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
    This report is a detailed and comprehensive analysis for global Endoscopic Hemostatic Powder market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Endoscopic Hemostatic Powder market size and forecasts, in consumption value ($ Million), sales quantity (Ton), and average selling prices (US$/Kg), 2021-2032
    Global Endoscopic Hemostatic Powder market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Ton), and average selling prices (US$/Kg), 2021-2032
    Global Endoscopic Hemostatic Powder market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Ton), and average selling prices (US$/Kg), 2021-2032
    Global Endoscopic Hemostatic Powder market shares of main players, shipments in revenue ($ Million), sales quantity (Ton), and ASP (US$/Kg), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Endoscopic Hemostatic Powder
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Endoscopic Hemostatic Powder market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BD, Johnson & Johnson, Qingdao Zhonghui Health Industrial Group, Pfizer, Success Bio-Tech, Hangzhou Singclean Medical Products, Medtrade Products, Beijing Tech-Bio-Med Medical Equipment, Baxter (PerClot), BioCer Entwicklungs, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Endoscopic Hemostatic Powder market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Polysaccharide Type
    Cellulose Type
    Gelatin Type
    Others
    Market segment by Application
    Hospital
    Clinic
    Others
    Major players covered
    BD
    Johnson & Johnson
    Qingdao Zhonghui Health Industrial Group
    Pfizer
    Success Bio-Tech
    Hangzhou Singclean Medical Products
    Medtrade Products
    Beijing Tech-Bio-Med Medical Equipment
    Baxter (PerClot)
    BioCer Entwicklungs
    Hemostasis
    Qingdao Biotemed Biomaterials
    Aegis Lifesciences
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Endoscopic Hemostatic Powder product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Endoscopic Hemostatic Powder, with price, sales quantity, revenue, and global market share of Endoscopic Hemostatic Powder from 2021 to 2026.
    Chapter 3, the Endoscopic Hemostatic Powder competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Endoscopic Hemostatic Powder breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Endoscopic Hemostatic Powder market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Endoscopic Hemostatic Powder.
    Chapter 14 and 15, to describe Endoscopic Hemostatic Powder sales channel, distributors, customers, research findings and conclusion.

    Buy now